Skip to main navigation Skip to search Skip to main content

KINECT HD 2: Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated with Huntington Disease

Project: Research

Project Details

StatusActive
Effective start/end date09/8/21 → 08/1/26

Funding

  • Huntington Study Group: $139,442.20